Drug | Tenu Tech Brief

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

• Vivtex’s technology uses AI and high throughput screening to identify the combinations of drug ingredients that can deliver peptides through gastrointestinal tissue • Besides Nov

Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA

• The FDA asked for more data to determine whether Disc Medicine’s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. • Analysts say it’s